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FELINE RENAL ALLOGRAFT TRANSPLANTS
Abstract
In recent years, kidney transplants have become a viable treatment option for chronic
kidney disease in felines. Chronic kidney disease is the leading disease in geriatric cats
with 20% of these geriatric cats being affected. Feline kidney transplantation has been
met with many different issues regarding ethics, diagnosis, methods, and complications.
There are some individuals that believe kidney transplants should not be done in felines
because consent from the feline cannot be obtained. The diagnosis of chronic kidney
disease has been on the rise in recent years which may be due to new classification
standards. There have been many different methods used to carry out the vascular
anastomosis and ureteroneocystostomy. There have been many improvements of these
methods to help reduce complications and mortality.
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The Advancements of Feline Renal Allograft Transplantation Techniques and Treatments
The first organ transplant was attempted using animal donor and recipients in the
early 20th century (Bleedorn, 2008). According to Bleedorn (2008), in recent years organ
transplantation has become more common in both humans and animals. Some
successfully transplanted organs include corneal, bone marrow, and kidneys. Live donors
are preferred over cadavers, but cadaver organs are often used because of the lack of
living donors. The first renal transplant was performed at the University of CaliforniaDavis School of Veterinary Medicine in 1987 for chronic kidney disease in cats
(Bleedorn, 2008). This treatment for felines was not described in literature until 1992
(Budgeon, 2017).
Bleedorn (2008) explained that kidney transplantation is another option besides
long-term peritoneal dialysis or hemodialysis. It is also an alternate option to treating
end-stage kidney failure. This option is often chosen due to greater survival time and
quality of life. The mortality rate in kidney recipients within the first year in one study
was found to be 5%. The increased survival time and low mortality rate is due to the
development and success of new surgical methods, pre-transplant screening, matching
between the recipient and the donor, and immunosuppressive treatments. The average
length of time a feline can live after transplantation has not been adequately determined
due to loss of contact with the feline owner and/or the research ended before the death of
the feline (Bleedorn, 2008).
Kidney transplants have been shown to work in both felines and canines.
Bleedorn (2008) explained that kidney transplants have been shown to be much more
effective in felines compared to canines. This is mainly due to canines needing a higher
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level of immunosuppression to avoid renal allograft rejection. The number of surviving
felines has increased with the advancements of surgery techniques and
immunosuppressive treatments (Bleedorn, 2008).
Chronic Kidney Disease
According to Bleedorn, chronic kidney disease (CKD) is the most prevalent
disease in geriatric cats, with a reported 1.6% to 20% of geriatric cats affected. In cats
older than 15 years the occurrence of renal failure increased from 12% to 30% (Bleedorn,
2008). The prevalence also increases as the age of the cat increases even when the cats
are under 15 years old (Danielson, 2015). Danielson (2015) explained, that in recent
years the prevalence of CKD has increased which may be due to new surveillance and
classification systems. It could also be due to the changes in the environment or dietary
issues (Danielson, 2015).
One characteristic of CKD is irreversible histological changes due to structural or
functional injury of the kidney (Bleedorn, 2008). These changes can be evaluated by
preforming a urinalysis, complete blood count, a serum chemistry profile and diagnostic
imaging. Bleedorn (2008) explains that by the time kidney dysfunction is found in cats
through standard tests it must be assumed that kidney disease is severe, but there are still
different levels of severity found in these cats. The progression and severity of the
disease is determined by changes in creatinine and blood urea nitrogen electrolyte
concentrations, abnormal serum phosphorous concentrations, and packed cell volume
(PCV) or hematocrit with decrease in concentration of urine. The inability to properly
concentrate urine is associated with a 2/3 loss of functional nephrons. Even in this state,
some cats can concentrate their urine. These cats may be in renal failure without
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isosthenuria. Isosthenuria is where the excretion of urine does not have a higher or lower
concentration than the protein-free plasma. This shows that there has been damage of the
renal tubules and medulla (Bleedorn, 2008).
Management of Chronic Kidney Disease
According to Bleedorn (2008), the best management of CKD symptoms is a
mixture of diet and drug therapy, because it limits the physiologic and clinical
consequences of decreased renal function. The first step of managing chronic kidney
disease is identifying what is causing kidney dysfunction. There are different diet
recommendations based on the stage of CKD and the feline’s specific imbalances. There
is a particular balance between keeping appetite, maintaining body weight, and limiting
protein intake (Bleedorn, 2008).
In mild to moderate chronic kidney disease the patient must keep adequate caloric
intake to prevent malnutrition of protein (Bleedorn, 2008). Bleedorn (2008) suggests
restrictions of phosphorus, protein and sodium should start when azotemia remains
during the well-hydrated stage of kidney disease. Cats that are polyuric and uremic are
more likely to get dehydrated, which can cause progression in renal dysfunction. Because
of this, these patients must maintain adequate hydration. A few strategies that promote
adequate hydration is the use of drinking fountains, canned food diets, and providing
fresh water. If the patient is still not receiving adequate hydration, subcutaneous fluids
may be given. This can help the patient receive the proper hydration and increase the
quality of life (Bleedorn, 2008).
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Complications of Chronic Kidney Disease
In late stages of CKD anemia develops due to less erythropoietin being produced,
shorter erythrocyte survival caused by uremic toxins, and bleeding in the gastrointestinal
tract (Bleedorn, 2008). This can be corrected by administering recombinant human
erythropoietin but must be monitored due to risk of hypertension, polycythemia, and
formation of anti-erythropoietin antibodies. The other consequences and causes of renal
injury must also be addressed. This includes uremic gastritis, hypercalcemia,
hyperphosphatemia, metabolic acidosis, hypokalemia, and hypertension. These
consequences must be treated before the individual is considered for a kidney
transplantation (Bleedorn, 2008).
The decreased clearance of plasma gastrin causes uremic gastritis. Bleedorn
(2008) explains that this can also help determine the severity of CKD and is treated with
famotidine. Famotidine is a H2-receptor blocking agent that can help lessen the severity
of gastrointestinal ulceration thus increasing appetite (Bleedorn, 2008).
According to Bleedorn (2008) there are also different imbalances that can
negatively impact felines with CKD such as phosphate and calcium. Hyperphosphatemia
occurs after a low rate of glomerular filtration. These cats are given oral phosphate
binding agents if they cannot keep the normal serum phosphorous concentration with
dietary restriction of phosphorous. Calcitriol production may not work properly due to
interruption of calcium homeostasis which leads to the development of
hyperparathyroidism. Calcitriol supplements may be given but recipients’ serum
phosphorous and serum parathyroid hormone levels must be monitored to avoid negative
effects of toxicosis (Bleedorn, 2008).
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Metabolic acidosis aggravates azotemia and can cause more protein catabolism,
hypokalemia and muscle wasting (Bleedorn, 2008). Bleedorn (2008) suggests, if
metabolic acidosis is severe, alkalization therapy such as oral potassium citrate or sodium
bicarbonate should be given. Hypokalemia is found in 20-30% of cats with CKD. This
can make kidney disease worse and causes muscle wasting and weakness. Oral potassium
gluconate or potassium citrate is used to treat these abnormalities (Bleedorn, 2008).
According to Bleedorn (2008), 20% of cats get hypertension as a sequela of CKD.
Cats with continued elevated systolic blood pressure should be monitored for ocular
symptoms of hypertensive retinopathy. This includes retinal hemorrhages, blindness, and
retinal detachment. One drug used to control hypertension and decrease the occurrence of
ocular lesions is amlodipine which blocks the calcium channels (Bleedorn, 2008).
Multiplicity of Veins and Arteries
Cáceres (2008) explains humans are more likely to have multiple renal veins on
the right and multiple renal arteries on the left. Felines have been found to have these
same trends in renal veins and arteries. In one study it was found that cats have the
greatest risk for multiple right renal veins compared to multiplicity in the left renal vein
and both renal arteries (Cáceres, 2008).
In both humans and felines, it is 4 times more common to have multiple renal
veins on the right (Cáceres, 2008). This is due to embryologic formation of renal veins.
There are three pairs of veins in an embryo. These veins are the supracardinal,
subcardinal, and postcardinal. Anastomosis of the subcardinal and supracardinal forms
the right renal veins. This includes two primitive veins and makes the renal section of the
vena cava. The left subcardinal vein goes through degeneration to make the left renal
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vein. Since the left vein is formed from only one primitive vein it is less likely to make
multiple renal veins. This can help explain why multiple veins are more common on the
right compared to the left (Cáceres, 2008).
According to Cáceres (2008), in some felines there has been the presence of a
double vena cava which can also be linked to the embryological development. The
embryologic development of the inferior vena cava is very intricate and includes a
complex process involving regression, fusion, and growth of the three vein pairs. The
double caudal vena cava is formed from both of the supracardinal veins because of the
persistence of the veins. Usually, the left vena cava stops at the left renal vein in
individuals with this abnormality. It then crosses the aorta anteriorly to connect with the
right caudal vena cava. At the hepatic level it then forms only one vein. These felines also
typically have short renal veins that may be abnormal (Cáceres, 2008).
Cáceres (2008) points out that multiple renal arteries can also occur during
embryonic development. During this development time the embryonic kidneys move up
from the pelvic region. During this move the arterial supply changes from the caudal
arteries to cranial renal arteries. The cranial arteries originated from the adrenal artery
whereas the caudal artery came from iliac arteries. The main renal artery is developed
through anastomosis of the aortic branches and degeneration of the secondary cranial
branches. If these branches fail to degenerate they can result in multiple, polar, or
accessory renal arteries (Cáceres, 2008).
Transplant Consideration
Bleedorn (2008) suggests that feline kidney transplants should be considered in
cats with acute, irreversible renal failure, or decompensated chronic kidney disease.

FELINE RENAL ALLOGRAFT TRANSPLANTS

10

Common pathological conditions that indicate possible transplantation include renal
fibrosis, chronic interstitial nephritis, ethylene glycol toxicosis, and polycystic kidneys.
Other less common conditions include glomerulonephritis, renal dysplasia, amyloidosis,
pyogranulomatous nephritis, pyelonephritis, or nephrosclerosis secondary to drug
toxicosis. In one study of cats with CKD considered for transplants, 15% were found to
have glomerulonephropathy and 70% had tubulointerstitial nephritis (Bleedorn, 2008).
Outcome Predictions
Schmiedt (2008) explains, there are multiple components that are evaluated by
ultrasound that may help predict the outcome of kidney transplantation. These
components include echogenicity, corticomedullary demarcation, cortical blood flow,
resistive index, and graft size. The resistive index (RI) is a value that describes the timevelocity wave form of the pulsatility of the intrarenal artery. This value may provide
some predictions for the outcome of the transplant, but it is controversial. The only cases
where RI was found to be high was in Schmiedt’s study with grafts that had a thrombosis.
The RI did not help with evaluating grafts with ureteral obstruction, DGF, or acute
rejection. Graft volume was determined to be a better predictor of graft disease than RI. It
was found that the graft volume was larger in grafts with acute rejection and ureteral
obstruction (Schmiedt, 2008).
In Schmiedt’s (2008) study, there was a positive correlation found between RI
and the cyclosporine A concentration. Decreased glomerular filtration rate in acute
cyclosporine A toxicity is due to vasoconstriction of the renal arteriole by a thromboxane
mediated mechanism. There is also a decrease in renal blood flow due to the increased
resistance in the renal vascularity. Acute cyclosporine A toxicity is an increase in the
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serum creatinine concentration with an increased level of cyclosporine A in the whole
blood concentration. This can be fixed with the decrease in cyclosporine A blood
concentration. Schmiedt (2008) shows that RI may help determine the acute toxic
impacts of cyclosporine A.
Ethics Associated with Kidney Transplantation
Ethical issues have also been discussed regarding the use of living feline donors.
In humans, the use of living donors is accepted for kidney transplants since most of the
population has two normal functioning kidneys. Humans are also able to give their verbal
and written consent whereas animals cannot. Some people would consider the taking of
an organ from a nonconsenting animal donor as animal abuse because it would cause
unnecessary pain and suffering. But, since veterinarians never have consent from the
animal for any procedures performed on animals and most procedures done for the
animal’s benefit and their survival, the consent is implied. Consent can also be given by
the animal owner.
Another issue that has been raised is what will happen to the animal after it
donates its organs. One answer to this question that has been suggested is to find a caring
home for these animals after their donations. Many of the transplant programs have
responded to this suggestion by required adoption of the donor cat even if the recipient
does not have a good outcome (Bleedorn, 2008). According to Yeates (2014), kidney
transplantation in animals is currently acceptable in New Zealand, Australia, and the
United States. These procedures were allowed in the United Kingdom but were
discontinued and under review in 2013 to determine if it was ethical (Yeates, 2014).
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At a meeting of the Royal College of Veterinary Surgeons (RCVS) in 2016, the
issue of ethics and feline kidney transplants in the UK was discussed (Kidney Transplants
in, 2016). At this meeting, they pointed out that there are no major issues with using
kidneys from donors that have already been euthanized. Some people would argue that
this would be mutilation of an animal, thus it would be illegal to carry out these
transplantations even if the donor is no longer living (Kidney Transplants in, 2016). This
would also impact transplants from animals to humans since these animals are euthanized
before using their organs in humans.
Jerry Davies, who attended the RCVS meeting, wanted there to be a rule that all
transplant organs and living tissues must be from nonliving donors. If the donor was not
dead, it would be unacceptable to harvest their organs. Other council members did not
agree with Davies and mentioned that other procedures such as artificial inseminations,
embryo transfers, and blood transfusions would fall under this category of materials taken
from a living individual. This means that these procedures would also be illegal by
Davies’ ideal standards (Kidney Transplants in, 2016).
Pre-transplant Screening
Screening of Recipient Cats
Bleedorn (2008) suggests an extensive list of evaluations that both recipient and
donor cats must go through before donating or receiving a kidney. The recipient cats
must be examined by evaluating total serum thyroxine concentration, blood type,
Toxoplasma gondii IgG and IgM titers, thoracic radiography, electrocardiography and
echocardiography, FIV and FeLV testing, serum chemistry profile, blood count with
differential cell count, abdominal ultra-sonography, urinalysis with aerobic urine culture

FELINE RENAL ALLOGRAFT TRANSPLANTS

13

and sensitivity treatment, and cyclosporine challenge with repeat urine culture. The cats
must also be checked for any other conditions that they may have before kidney
transplantation. Some of these conditions include urinary tract infections, neoplasia,
diabetes mellitus, cardiac disease, poor body condition, cachexia, uncontrolled
hyperthyroidism, FeLV or FIV infection, fractious temperament or noncompliant owners,
and any other uncontrolled diseases (Bleedorn, 2008).
Bleedorn (2008) suggests that if a cat that has a negative urine culture but has had
urinary tract infections they must go through a 2-3 week cyclosporine challenge. A
second urine culture must be performed after this period. If the culture is positive the cat
is treated for chronic pyelonephritis after which another culture is taken. If this culture
comes back positive the cat is eliminated as a recipient for a kidney transplant. Cats with
feline leukemia virus (FeLV) or feline immunodeficiency virus (FIV) also cannot receive
transplants due to the increased infection risks after immunosuppression treatment
(Bleedorn, 2008).
Felines that have serum titers against Toxoplasma gondii antibodies may not be
infected but should be considered to have a larger risk for getting clinical toxoplasmosis
after taking immunosupressive drugs (Bleedorn, 2008). According to Bleedorn (2008),
Hyperthyroidism often occurs alongside of CKD and must be treated before
transplantation. This is due to hyperthyroidism aggravating CKD and decreasing the rate
of glomerular filtration. There are also challenges with anesthesia for felines with endstage kidney disease due to the abnormal renal physiology and pharmacokinetics. A
cardiac evaluation must be conducted because of the risks of anesthesia and shorter
lifespan in cats with severe cardiac disease (Bleedorn, 2008).
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Bleedorn (2008) suggests that, CKD impacts all the following systems in
interrelated and individual ways. These systems include the neurological, endocrine,
hematopoietic, cardiovascular, metabolic, immunologic, gastrointestinal, and pulmonary.
There are several metabolic derangements that can be present such as uremia, acidemia,
anemia, hyperphosphatemia, and hypocalcemia. If a recipient is found to have any of
these derangements, they should be treated pre-transplantation if possible. If patients
were treated with recombinant human erythropoietin and cannot delay transplantation,
the anemic felines are given a blood transfusion to get a PCV >30% before
transplantation. Pre-transplant, the patients should also get parenteral fluid diuresis with
solutions with balanced electrolytes (Bleedorn, 2008).
Screening of Donor Cats
Bleedorn (2008) points out that donor cats must also go through a similar
evaluation process as recipient cats. It is crucial to evaluate the function and anatomy of
the urinary tract to determine if it is suitable to use for transplantation. This is performed
by computed tomography angiography, abdominal ultrasonography or excretory
urography. Cats that are positive for anti-Toxoplasma gondii antibodies, FIV or FeLV are
not used as donors (Bleedorn, 2008).
Screening of Vascular Anatomy
Cáceres (2008) explains that the evaluation of the donor renal vascular and
urogenital anatomy is done pre-operatively to determine any abnormalities. Some of
these abnormalities include: abnormal renal parenchyma, renal calculi, and collecting
systems. Multiple arteries also pose a major problem due to the requirement of more than
one artery anastomosis. This increases the surgery time which also increases ischemia
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and anesthesia time. Multiple anastomoses have also been linked with higher risk of
bleeding and need for blood transfusions. Longer surgery time also comes with more
complications such as graft injuries. These injuries may cause more inflammation,
rejection episodes, premature graft loss, and graft immunogenicity (Cáceres, 2008).
According to Cáceres (2008), the most accurate way to pre-operatively scan a
human’s vascular anatomy is the use of multislice computed tomography (CT). CT
technology has >97% accuracy for arteries and 96-100% accuracy for veins in humans.
CT scans can also find mineralization of collecting system or cortico-medullary junction,
nodular fat necrosis, mesenteric lymphadenopathy, irregular kidneys, accessory renal
arteries, double caudal vena cava, and splenomegaly (Cáceres, 2008).
In Cáceres’ (2017) study with felines there was a 92% agreement between
surgical left renal vascular anatomy and the CT angiography findings. The common
disagreement was double renal arteries that were not shown on the CT. This may have
occurred due to the close placement of arteries to each other. In humans, CT has a higher
agreement rate because of the multislice CT angiography with better resolution and the
much larger renal vessels compared to felines (Cáceres, 2017).
Cáceres (2008) mentioned, that accessory renal arteries are not common in felines
but can be seen in 25% of human patients. These accessory arteries are often missed in
CT angiography due to their small size. This is the biggest disagreement between CT
angiography and actual anatomy of a human patient. Multislice CT angiography has
become the standard technology to use to screen vascularity before surgery. This is due to
the better special resolution, less tube heating, short acquisition time for images, and
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ability to view larger image volumes with no decrease in signal-to-noise ratio (Cáceres,
2008).
Budgeon (2017) showed early phase conventional intravenous urogram (IVU)
could be used to preoperatively determine the anatomy of vascularity. IVU has a failure
rate of about 10% so it is not used as often to check the vascular anatomy compared to
CT technology. Budgeon (2017) explained, that all of these evaluations are excluded by
some surgeons because of the low occurrence of multiple arteries and extra costs for the
screening. These screening options can also miss multiple arteries which makes the cost
of doing the screening worthless because the surgeon would not know until the patient is
open on the table and the surgery cannot be completed.
Methods Used During Transplantation
General Techniques and Medications
Bleedorn (2008) explains that there are multiple techniques used for ureteral
implantation and vascular anastomosis but they all use the same general monitoring and
anesthetic procedures. Hemodynamic parameters are ideally monitored by a jugular
catheter before, during, and after the procedure. The typical anesthetic and premedication
protocol include an opioid, anticholinergic, and an inhalant anesthetic. Which agents are
used depends on the pre-transplant evaluation and the anesthesiologist’s preference
(Bleedorn, 2008).
Bleedorn (2008) explains that broad spectrum antibiotics are given for the
duration of the surgery. During microvascular anastomosis, atracurium besylate is
administered if needed to keep the muscles relaxed. The systolic blood pressure can be
kept at an adequate level by the continuous-rate infusion of dopamine in donor cats prior
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to nephrectomy and in recipients post vascular anastomosis. Mannitol can be
administered to induce osmotic diuresis, which also helps minimize acute tubular
necrosis that is related to temporary ischemia. During the operation, the typical
physiological parameters are constantly monitored and, if needed, adjustments to the
drugs are made. Electrolytes along with venous or arterial blood gas are monitored
occasionally and any imbalances are corrected (Bleedorn, 2008).
Preservation Solutions
Katayama (2014) found that cold phosphate-buffered sucrose (PBS) was a better
preservation solution than cold heparinized saline (HS) solution for feline kidney
allografts. Sucrose is a good osmotic agent due to its size and its decreased ability to
cross the cell membrane. A hyperosmotic solution is used due to the theory that it
decreases cellular swelling because it balances the intracellular colloid osmotic pressure.
This balancing act helps protect the graft. When using PBS, the serum creatinine levels
did not vary shortly after the operation unlike the HS solution. This shows that PBS may
prevent injuries such as reperfusion and ischemia (Katayama, 2014).
Vascular Anastomosis
Bleedorn (2008) described the typical vascular anastomosis techniques. A ventral
midline celiotomy is used to remove the donor cat’s kidney. A dissecting microscope is
used to help vascular dissection. Both donor kidneys are evaluated for multiple veins and
arteries, and appropriate kidney function for transplantation. The kidney from the donor
must have only one supplying artery. Transplantation of the left kidney is ideal due to the
longer length of the vascular pedicle. The length of the artery must be at least 0.5 cm to
perform the arterial anastomosis. The renal vein is measured in order to make a sterile
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template to help create the donor phlebotomy site. Before nephrectomy the whole ureter
length is isolated from the urinary bladder to the kidney (Bleedorn, 2008).
Budgeon (2017) explains some of the historical techniques used for anastomosis.
The original techniques used for these transplantations required ureteral drop-in and endto-end renal-to-iliac artery anastomoses (Budgeon, 2017). In previous studies, the
external iliac vessels were used for anastomosis, but these cats had complications with
rear limbs. In more recent articles, the postrenal aorta and vena cava were used during
anastomosis (Bleedorn, 2008). Since the first transplants, the procedures have greatly
improved. This combined with better patient management has decreased complications
and death (Budgeon, 2017).
The common technique now includes anastomosis of the end of the renal artery to
the side of the aorta and the end of the vein to the side of the vena cava. This technique is
also simpler and faster than the previous technique used. Some complications that are
decreased by the current technique include pain, edema, paresis or paralysis, and
ipsilateral pelvic limb hypothermia. Even though this procedure decreases these
complications it did not change any complications linked to vascular anastomoses. One
challenge that can arise is double arteries to the donor’s kidneys. Most of the time the left
kidney is preferred, but the right will be chosen for transplantation if the left has multiple
arteries. Implantation of the right kidney is technically more difficult due to a shorter
artery to vein length. The right kidney also lines up better to be transplanted on the right
side of the recipient which is not the prepared side of the recipient (Budgeon, 2017).
Bleedorn (2008) illustrates that the area between the caudal mesenteric artery and
left renal artery of the recipient cat should be expose and isolated. This is done to prepare
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the donor for the graft. The kidney from the donor is not harvested until the vessels in the
recipient are ready for implantation. 8-0 to 10-0 nylon is used for the donor’s renal artery
which is anastomosed end-to-side to the aorta. This is done in a simple interrupted
pattern. 7-0 silk is used while the renal vein is anastomosed to the caudal vena cava. This
is done with simple continuous sutures and is done in two rows (Bleedorn, 2008).
Carrel Patch Method
In 1905 Alexis Carrel described the carrel patch which is a technique used for
vascular anastomoses (Budgeon, 2017). According to Budgeon (2017), this technique is
widely used today in vascular surgery. Using a carrel patch in kidney transplantation
means that a patch of the aorta centered above the renal artery or arteries is removed. In
human kidney transplantation this method is thought to help reimplantation and decreases
the risk of thrombus formation. This technique when used in felines would allow the use
of a donor kidney that has multiple renal arteries (Budgeon, 2017).
Budgeon (2017) explains that a dorsal recumbency position was given to the
donor feline when using the carrel patch method. Then a ventral midline celiotomy is
conducted. The pathology of both donor kidneys is examined. Dissection of the perirenal
fat is done to expose the renal artery and vein. Next, transection and ligation was
performed on the ureter close to the entrance to the bladder or it is resected with the
ureteral papilla. Before vessel occlusion all preparations are finished. This is done to limit
the occlusion time of the aorta of the donor and warm ischemia time of the graft. A
Satinsky clamp was placed tangent to the aorta’s long axis to seclude the left kidney
arteries without occluding the right renal arteries. The incision on the aorta is done with a
specialized scalpel blade and is lateral to the single or multiple renal arteries with a

FELINE RENAL ALLOGRAFT TRANSPLANTS

20

Vannas scissor. The incision is extended around the single or multiple renal arteries with
1mm of tissue from the base of the vessels. Transection of the renal vein occurs after it is
clamped and is done close to the vena cava with standard techniques. After the kidney is
removed, CDId sucrose-phosphate preservative is used to flush the vessels and is
submerged in the cold solution over ice until the time of graft implantation (Budgeon,
2017).
According to Budgeon (2017), 9-0 nylon is used to close the donor aorta in an
overlapping simple continuous pattern. The Satinsky vascular clamp is then taken off the
aorta. 4-0 silk is used to ligate the donor’s renal vein and the vein is checked for
hemorrhaging. The abdomen is closed in a common manner. In the recipient cat, 10-0
braided polyester sutures are used to complete the venous anastomosis in an end-to-side
fashion. This is done after the vena cava is partially occluded by using a #7 Sundt
slimline temporary aneurysm clip. A Cooley neonatal vascular clamp is used to isolate
part of the aorta. A small patch, about the size of the donor patch, is cut out of the aortic
wall. 9/0 nylon is used for 2 simple continuous suture patterns to suture the donor patch
into the recipient’s aorta (Budgeon, 2017).
Budgeon (2017) explains two different techniques were used to implant the ureter
in carrel patch method kidney transplantations. In one method, a neouretercystostomy is
done, and in the other method there is an implantation of the ureteral papilla
extravesicularly. 5-0 polyglactin 910 sutures are used to tact the renal capsule to a fold of
the peritoneum. The abdomen is closed using common procedures. The major outcome
predictor factor is the length and diameter of the renal artery. The shorter the blood
vessels the more complicated the procedure. The smaller the diameter of the renal arteries
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increases the risk of inaccurate apposition and thrombosis. Due to these factors larger
donor cats are ideal due to larger kidneys and vessels (Budgeon, 2017).
Budgeon (2017) suggested using the carrel patch method when the kidney is
found to have multiple arteries at the time of surgery because it makes the kidney usable.
The carrel patch method also allows surgeons to pick the left kidney over the right even if
there are multiple arteries. The carrel method may be beneficial to use in single artery
transplants as well. This is due to graft destruction and thromboembolic events still being
major complications of kidney transplants. If there is a gap at the anastomic site within
the epithelium there may be exposure to collagen. This may cause a formation of a
thrombus. Due to the difficulty of the 90-degree end-to-side anastomosis, the correct
positioning of the epithelium may be hard to achieve. The carrel patch method can lower
this risk by having the suture line away from the renal artery entrance (Budgeon, 2017).
Theoretically, the reducing of the angle of contact of the aortic wall and vessel
tissue can aid endothelial apposition, which decreases the risk of formation of a thrombus
(Budgeon, 2017). Some surgeons find placing the carrel patch in the aortic wall
technically easier than the end-to-side method. For the carrel patch method to work, the
surgeon must realize that the feline aorta is comparatively small, particularly the
circumference. This means that the patch must be very small, approximately 1mm around
the vessel. Budgeon (2017) recommends making an eclipse shaped incision parallel to the
length because it makes closing the aorta simpler. The patch is best removed by
microsurgical scissors instead of a scalpel (Budgeon, 2017).
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Ureter Removal Techniques
Bleedorn (2008) explains that there have also been multiple techniques used to
implant the donor ureter in to the recipient’s urinary bladder. One technique uses an
extravesicular ureteroneocystostomy. This technique is said to be the fastest fix for
mucosal apposition of the donor ureter to the recipient’s bladder and renal pelvic dilation.
Both of these decrease the occurrence of obstruction postoperatively. A peritonealtransverse abdominis muscle flap is made, then the renal capsule is connected to the
abdominal wall. This prevents kidney torsion on the pedicle (Bleedorn, 2008).
Danielson (2015) explained that the technique used to harvest the kidney along
with ureter before 2003 involved the transection and ligation of the distal ureter at the
urinary bladder. This is called the ureteral transection (UT) technique. After 2003, this
procedure was modified to harvest all of the ureter along with all ureter papilla and a part
of the bladder wall. This is called the ureteral papilla harvest (UPH) technique. The UPH
technique is not as technically challenging and could lessen the risk of dehiscence,
obstruction, and leakage at the neoureterocystostomy site compared to the UT technique
(Danielson, 2015).
Danielson (2015) lists the different medications used before, during and after
neoureterocystostomy. During this procedure the cats are first given an opioid, usually
oxymorphone in a dose of 0.05-0.1 mg/kg intramuscularly (IM). They are also given a
benzodiazepine or a phenothiazine. The usual benzodiazepine given is midazolam (0.250.5 mg/kg IM) and the typical phenothiazine is acepromazine (0.05-0.1 mg/kg IM).
Induction of anesthesia is induced by 10-15 mg/kg of thiopental or 2-6 mg/kg of
propofol. Both of these drugs would be given intravenously. Anesthesia is maintained
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with the administration of isoflurane. Fluids are given intravenously at 5-10 mL/kg/h
during the surgery. 30 minutes before the kidney is harvested, the renal perfusion is
increased by administering 0.5 mg/kg of mannitol intravenously and 0.01 mg/kg of
acepromazine. Once the kidney is removed, 20 mg/kg of prophylactic antibiotics was
given intravenously (Danielson, 2015).
Danielson (2015) explains that the UT method involves dissection of the ureter
from the peritoneal attachments. 3-0 or 4-0 silk is used to ligate the ureter. Transection of
the ureter occurs approximately 1-2 cm next to the ureterovesicular junction. The UPH
technique involves the use of an operating microscope to harvest the whole ureter and 2-3
mm cuff of the bladder wall that surrounds the ureteral papilla. Microdissecting scissors
are used to make the circular cut around the ureteral papilla. This is done carefully to
avoid injuring the contralateral or ipsilateral ureteral stoma. Two layers of 6-0 polyglactin
910 sutures are used to close the defect in the bladder. After surgery the felines are given
opioids for postoperative analgesia. If cats are in the ICU they are given crystalloid fluid
therapy at doses of 60-80 mL/kg per day through IV. The surgery time in one study was
55 minutes for the UT technique and 93 minutes for the UPH technique (Danielson,
2015).
Mehl (2005) also explained that there have been a number of techniques used for
ureteroneocystostomy in felines. The original technique used was a “drop-in” where the
ureter is put into the bladder wall through a small opening and is held in place by only
one transmural suture. Complications linked with this technique include granuloma
formation at ureterovesicular junction which can cause ureteral obstruction and
hemorrage. A mucosal apposition technique reduces inflammatory response and
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formation of granulomas. This technique requires eversion of the bladder mucosa and a
ventral cystotomy. One issue that may occur is major swelling of the bladder after
eversion which can increase the difficulty of suturing the ureteroneocystostomy. These
intravesical techniques have been replaced with extravesical ones because they do not
need a different cystotomy for access (Mehl 2005).
Mehl (2005) explains the procedure for a intravesical mucosal apposition
ureteroneocystostomy. After the ventral cystotomy is performed hemostatic forceps are
used to bring the ureter through the bladder’s craniodorsal surface. The bladder mucosa is
exposed by everting the bladder. After the spatulation of the distal end of the ureter and
the ureteral artery bleeding occurred, it was ligated with 6-0 polydioxanone. 8-0 nylon
was used to appose the ureteral and bladder mucosa with 6-8 simple interrupted sutures.
To ensure openness during the suture placement a 4-0 polypropylene stent was put into
the ureteral lumen. This stent was removed before the closure of cystotomy. All of the
sutures were made through the full thickness of the ureteral and bladder mucosa. 3-0
polydioxanone was used to close the cystotomy site in a simple continuous pattern. 0.9%
NaCl sterile saline solution was injected into the lumen and pressure was applied to check
for any leakages (Mehl, 2005).
Mehl (2005) also explained the procedure for an extravesical
ureteroneocystostomy. The mucosa of the ventral part of the apex of the urinary bladder
was exposed by an incision through the muscularis and submucosa. Spatulation of the
distal end of the ureter was performed and an equal size incision was made in the bladder
mucosa. The previously mention stent was also used to ensure openness but was placed
after two sutures were completed and removed before the last suture. 8-0 nylon was used
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to suture the full thickness of the ureter and bladder mucosa. This was done with different
sutures in different patients. In some feline patients, a simple continuous pattern was
used. In this method, there were two sutures completed between the proximal ureter
where it was spatulated and the cranial aspect of the bladder incision. One suture was
between the caudal aspect of the bladder incision and the distal ureter. These were both
the first knots of two different continuous suture lines. In other felines a simple
interrupted suture pattern was used. The sutures were placed in the same locations as the
other patients and were cut to make two simple interrupted sutures. Two more of these
sutures were done between the ureteral and bladder mucosa. After the completion of
suturing, the muscularis and bladder serosa were apposed with a simple interrupted
pattern of 4-0 polydioxanone. Sterile saline solution was injected to check for any leaks
(Mehl, 2005).
According to Sutherland (2016), about 70% of kidney recipients survive a year
after transplantation when using the ureteral papilla implantation method. Eighty-five
percent of the felines had fast normalization of the serum creatinine levels. This method
is easier to suture because of the larger size and being able to place sutures a few
millimeters from the stroma. Since these sutures are not placed in the lumen of the ureter
there is a decrease in the risk of granulation formation and obstruction caused by
swelling. The fast normalization time may have also been helped by the kidney perfusion
with cold sucrose phosphate preservation solution right after it was harvested. The cold
preservation has shown to help early graft function and limits the loss of nephrons due to
ischemic injury. This method does come with some concerns such as the longer time
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required to resect the ureteral papilla and swelling or accidental injury of the contralateral
ureteral stoma during the procedure (Sutherland, 2016).
Danielson (2015) explained that there are some potential negative consequences
to unilateral nephrectomy such as increased blood pressure and urine protein excretion
than pre-nephrectomy. After unilateral nephrectomy there is also a decrease in both
effective renal plasma flow and total glomerular filtration rate (GFR). These two
decreases are still 50% higher than the pre-nephrectomy function which shows that the
remaining kidney has adapted. Even though there are some negative sequelae to
unilateral nephrectomy it has not shown to increase the occurrence of end stage kidney
disease or survival time of donors (Danielson, 2015).
According to Danielson (2015), there was not a statistical difference between the
number of minor complications between these two techniques (UPH and UT). Short-term
complications were defined as any complications that occurred during the nephrectomy
hospitalization. In the cats receiving the UPH technique some minor short-term
complications were transient urine retention, fever, swelling of the incision in the
abdominal wall, mild pneumomediastinum, and azotemia. Some of the UT cats have had
the following minor short-term complications: seroma of abdominal wall, minor skin
dehiscence of incision in abdomen, and viral infection of the upper respiratory tract.
There was also no significant difference between long term complications. One minor
long-term complication that occurred in UT patients was linked to the urinary tract. One
major long-term complication that occurred in one UPH and four UT patients was kidney
failure (Danielson, 2015).
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Mehl (2005) explained, that the cats with the extravesical-simple continuous
sutures had higher serum creatinine concentration and mortality rate. This may be due to
the “purse string” effect that occurs with these sutures and causes ureter obstruction. The
cats with extravesical-simple interrupted sutures had decreased size in bladder mass,
renal pelvic dilation and serum creatinine concentration. These decreases make the
simple interrupted sutures the better technique in cats (Mehl, 2005).
Immunosuppressive Treatments
According to Bleedorn (2008), early kidney allograft transplants were successful
technically but eventually rejected. The survival length of these allografts increased after
the invention of immunosuppressive drugs in the 1960’s. The development of these
immunosuppressive drugs was the most important advancement in transplantation
procedures. These drugs allow transplantation from unrelated individuals because they
help prevent rejection of the foreign tissues. The rejection of foreign tissue is due to Tcell mediated recognition of the important histocompatibility complex proteins on a cell’s
surface and the peptides they present. Acute rejection occurs in 5 to 8 days when
transplanting kidneys from histoincompatible, unrelated donors. The recipient must stay
on immunosuppressive drugs for the rest of their life span to prevent rejection of the
foreign tissue (Bleedorn, 2008).
Cyclosporine was one of these drugs that changed the survival time due to the
selective inhibition of the T lymphocytes, which is the main type of cells that cause
kidney allograft rejection (Bleedorn, 2008). Katayama (2012) explained that cyclosporine
is isolated from Tolypocladium inflatum which is a fungus and a cyclic polypeptide. This
molecule is lipophilic and has immunosuppressive qualities. Cyclosporine inhibits the
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production of interleukin(IL)-2 which signals activation and proliferation of T-cells. This
causes suppression of various cytokine’s secondary synthesis (Katayama, 2012).
According to Bleedorn (2008), a combination of prednisone and microemulsified
cyclosporine is typically used for immunosuppression treatment. Some transplant
locations suggest starting cyclosporine 2 weeks before transplantation, so the serum
trough levels are good at the time of the transplant. This helps avoid the start of the host
vs. graft immune response. Prednisone (0.25 mg/kg) is also given to the patient pretransplantation. Cyclosporine is given every 12-24 hours in 3 to 5 mg/kg doses to get
500ng/mL whole blood trough concentration for the first month after surgery. After this
time, it is decreased to be 150-250 ng/mL for the duration of their life. This dose is given
every 12 hours for the first month after surgery and then only once a day after that
(Bleedorn, 2008).
According to McAnulty (1999) some drugs that could lower cyclosporine
elimination and increase the cyclosporine concentration in the blood are antibiotics,
antifungals, corticosteroids, calcium channel blockers, and antiemetics. Absorption of
cyclosporine occurs in the small intestine and is excreted in bile after being metabolized
in the liver. Intestinal P-450 oxidases metabolize cyclosporine in the intestines before it is
absorbed. Hepatic cytochrome P-450_IIIA microsomal enzymes mediate the metabolism
of cyclosporine in the blood (McAnulty, 1999).
According to Bleedorn (2008), there are a few different agents that can alter the
metabolism of cyclosporine. Katayama (2012) found that ketoconazole (Kcz) can be
given to recipients to lower the dosage of cyclosporine. Ketoconazole lowers the
metabolism of cyclosporine by inhibiting P-450 IIIA microsomal enzyme competitively
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(McAnulty, 1999). This shows that the metabolism of cyclosporine may be mediated by
the inhibition of P-glycoprotein (P-gp) and cytochrome P450 3A (CYP3A) which
cyclosporine is a substrate of (Katayama, 2012). But, Kcz has some negative side effects
like hepatotoxicity. If this occurs, the treatment with Kcz must be discontinued which can
cause acute allograft rejection (Katayama, 2012). Treatment with Kcz also requires
another pill, which can increase the difficulty administering treatment to the feline.
Katayama (2012) also found that Clarithromycin (CLM) is less toxic and can also
inhibit P-gp and CYP3A. CLM significantly raised the oral bioavailability of
cyclosporine. When given cyclosporine and CLM the dosage to prevent acute allograft
rejection was reduced from 2 times a day to once a day (Katayama, 2012).
Bleedorn (2008) explained that more issues have been found with canine kidney
transplantation due to higher levels of immunosuppression needed to avoid rejection of
the graft. In canines the rejection of transplants is frequent and severe. Triple-drug
immunosuppressive treatments with cyclosporine, azathioprine, and prednisolone have
been used in canines but still show little success (Bleedorn, 2008).
Monitoring After Transplantation
Monitoring Recipients
Bleedorn (2008) suggests taking blood pressure often during the first 12-24 hours
due to the possibility of severe postoperative hypertension. Esophagostomy or
gastrostomy tubes are used to give supplemental nutrition until patients start eating and
drinking on their own. Serum creatinine concentration, trough whole blood cyclosporine
concentration, PCV, and total plasma protein concentrations are evaluated every 24
hours. To evaluate the specific gravity of urine and the amount of urine in 24-hours, all
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the urine is collected. After 3 to 5 days all hemodynamic parameters and renal functions
should be back to normal. Graft rejection should be considered if the patient produces
isothernuric urine, anorectic, experiences continued increase in concentration of serum
creatinine, or depression. The urinary tract should be examined by ultrasonography to
evaluate renal graft perfusion and possibly identify hydroureter or hydronephrosis. If a
patient has these conditions, it may be a stricture issue where the ureter was implanted
instead of rejection of the transplant. Surgical fixes may be needed to fix this condition
and not just a change in medication like some other conditions (Bleedorn, 2008).
Bleedorn (2008) explains that an esophageal or gastric feeding tube can be used
for nutrition support postoperatively. After transplantation, the patients are not handled
and kept stress free. Any unbalances of acid-base or electrolytes are monitored and
corrected (Bleedorn, 2008).
Bleedorn (2008) suggests discharging recipient cats when the function of the graft
is acceptable and there is stability of the blood cyclosporine concentrations. Graft
function is considered acceptable if there is enough nutritional intake, good attitude, less
serum creatinine concentration, and the ability to concentrate urine. Weekly evaluations
need to be conducted for at least 4 weeks after discharge. At these appointments PVC,
body weight, serum creatinine concentration, whole blood cyclosporine concentration,
and total solid concentration must be determined. Urine cultures, complete blood count,
cyclosporine concentration, urinalysis, and serum chemistry profile must be evaluated
multiple times a year after the first 4 weeks post-surgery. These recheck appointments
should be every 2-3 months for the first year after surgery, and every 3-4 months there
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after. Any cats that are showing signs of illness should be rechecked more often
(Bleedorn, 2008).
Due to the lowered immune system of transplant recipients, they must be strictly
indoor pets (Bleedorn, 2008). According to Bleedorn (2008), these cats should still be
vaccinated and treated for parasites regularly. When vaccinating these felines, their
vaccines should be recombinant or subunit vaccines with killed or inactive viruses rather
than attenuated or modified-live vaccines (Bleedorn, 2008).
Monitoring Donors
Bleedorn (2008) points out that there are no specific monitoring needs for the
donor cats after surgery. Before the donor cat is released, the serum creatinine
concentration will be checked. There are also few long-term risks linked with kidney
donation. They do not recommend regular rechecks, but a baseline urine specific gravity
and serum creatinine concentration should be taken 1 to 2 months after surgery with
yearly rechecks (Bleedorn, 2008).
Complications After Transplants
Kidney Rejection
Kinns (2010) explains that some indications of acute kidney rejection that are
found with sonography technology are the resistive indices, echogenicity, and renal size.
It may be possible to better detect acute rejection and chronic allograft nephropathy by
using contrast-enhanced sonography to find any differences that occur in perfusion in the
donated kidney. This method of monitoring perfusion is also less invasive and does not
require anesthesia or radiation like magnetic resonance imaging, contrast-enhanced CT,
and quantitative renal scintigraphy methods. Two technologies that provide better images
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than the traditional doppler ultrasounds are contrast-enhanced power doppler ultrasounds
and contrast-enhanced harmonic ultrasounds. Most clinics have the ability to do contrastenhanced power doppler ultrasounds but lack the specific software to do contrastenhanced harmonic ultrasound (Kinns, 2010).
Danielson (2015) hypothesized that an increase in kidney failure in donor cats
could be due to 50% decrease in functional renal parenchyma, and can make the cat more
vulnerable to interstitial nephritis, toxic insult, infectious damage, and normal age-linked
nephron loss that would not be detected in cats with two kidneys. Another cause of
increased kidney failure is obstructive ureterolithiasis in cats with only one ureter rather
than two ureters (Danielson, 2015). For felines the most common antirejection therapy
for kidney rejection is methylprednisolone sodium succinate. Some treatment centers also
give intravenous cyclosporine (Bleedorn, 2008).
Post-Transplant Malignant Neoplasia
The high rates of post-transplant malignant neoplasias (PTMN) in transplant
recipients emphasizes the need for careful thorough monitoring (Wormser, 2016).
Durham (2014) found that there is a difference between the time of transplantation and
diagnosis of lymphoma for cats and humans. In humans, the majority of people that
develop lymphoma will be diagnosed within the first 12 months following
transplantation. Whereas in cats, the median time of diagnosis is 617 days after
transplantation (Durham, 2014).
Durham (2014) explained that in human transplant recipients one of the most
significant post-transplant complication is transplant linked malignancies. Transplant
recipients may have a lower mortality rate in recent years, but they have a 3-4 times
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higher rate of neoplasms than the control population. In humans and cats, one of the most
common PTMNs is lymphoma. Lymphoma is included in a large spectrum of posttransplant lymphoproliferative disorders (PTLDs). These PTLDs include heterogenous
clusters of lymphoid proliferations that are abnormal and usually B-cells. These disorders
include reactive polyclonal hyperplasia to aggressive non-Hodgkin’s lymphoma. In
humans, 90% of PTLDs are Epstein-Barr virus (EBV) linked to an improperly working
immune system caused by the immunosuppressive treatment that is used to avoid
rejection of grafts. Other PTMNs diagnosed in felines are poorly differentiated hepatic
tumor, hepatic neuroendocrine carcinoma, fibrosarcoma, meningioma, malignant
melanoma, nasal adenocarcinoma, renal sarcoma and carcinoma, and adrenocortical
carcinoma. The difference in Durham’s (2014) experiment and control group for
lymphoma was significant. The transplant recipients had a 6.7 times higher risk of
developing lymphoma than the control population (Durham, 2014).
According to Durham (2014), EBV invades naïve B-cells and changes the
differentiation process in the cells to be a memory phenotype. This virus can be latent
within the nonactive memory B-cells. During this time, only a small part of the EBV’s
genes are expressed which makes it difficult for the host’s immune system to locate and
destroy the infected cells. The B cells that show viral proteins, particularly surface
proteins like LMP-1 and those that go through neoplastic transformation are susceptible
to T-cell-mediated destruction. In people or cats with immunosuppression there is not as
much surveillance done by T-cells which allows for larger numbers of the EBV changed
B-lymphocytes to survive (Durham, 2014).
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According to Schmiedt (2009) there is not a clear link between PTMNs and
cyclosporine concentrations, but cyclosporine could still influence the development of
PTMNs. The increased occurrence of PTMNs could be influenced by the treatment with
cyclosporine. There are four ways that it is thought that cyclosporine might increase the
occurrence of PTMNs. First, the immunosuppression of this drug can cause the
recrudescence of some oncogenic viruses. Second, this drug causes T-cell apoptosis
which decreases the neoplastic cell clearance and immunosurveillance. Third, it can
encourage the presence of DNA mutation, and can have a lower ability to fix these
mutations. Fourth, there is a direct impact on the phenotype of cells from the
cyclosporine which makes them more invasive and causes other malignant characteristics
(Schmiedt, 2009).
Delayed Graft Function
Delayed graft function (DGF) is a risk factor for mortality in humans after
transplantation (Katayama, 2014). Katayama (2014) defined DGF in humans as the need
to have dialysis in the first 7 days post-transplantation. In animals, there is not as precise
a definition due to the short length of time the kidney allograft is preserved. A common
DGF cause in felines is swelling that can occur at the anastomosis site which may cause
ureteral obstruction (Katayama, 2014). According to Mehl (2006), in cats both ureteral
obstruction and ischemic injury can lead to delayed graft function. Lowering the
occurrence of ischemic injury can help prevent delayed graft function in felines.
Post-transplant Infections
Lo (2012) mentioned two different studies that have found the post-transplant
infection rate to be fairly high in felines. The rate of infection was 25% in one study and

FELINE RENAL ALLOGRAFT TRANSPLANTS

35

36.7% in another. The first major cause of mortality within the first year after
transplantation is acute or chronic rejection. The second leading cause is infections.
Infections post-operatively are higher in felines compared to the 14% that occur in human
transplant recipients. The common infections that occur in cats are broken into categories.
53% percent of infections were bacterial, 28% were viral, 13% were fungal, and 6.4%
were protozoal (Lo, 2012).
Bleedorn (2008) explains that there are some long-term complications that may
occur such as the increased risk for infection. This is due to immunosuppressive drugs.
Various types of infections can occur and require extreme treatment. Another common
complication is urinary tract infections. One serious complication that can occur is the
reactivation of chronic respiratory viral infections. When treating these infections special
consideration should be taken for nephrotoxic drugs and the impact of the drugs on the
half-life of cyclosporine (Bleedorn, 2008).
Hypophosphatemia
Paster (2009) observed that 19-93% of human renal transplant recipients will have
hypophosphatemia. This usually occurs shortly after the operation, but can still happen 10
years after the transplant. Hypophosphatemia has been linked with secondary hemolysis,
osteodystrophy, pathologic fracture, and decreased phosphorous reabsorption in the renal
tubules. Some possible causes of hypophosphatemia include glucocorticoid
administration, deficiency of vitamin D, secondary hyperparathyroidism, and disruption
of phosphate absorption hormone regulators. Thirty-seven percent of cats had
hypophosphatemia with most cases occurring within the first 35 days after
transplantation. Some other sequelae to hypophosphatemia include impairment of the
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neuromuscular, central nervous system, liver function, and the function of white blood
cells. There can also be a loss of bicarbonate and glucose in the renal tubules, lower
platelet function and compromised myocardial contractility, that can be reversed (Paster,
2009).
Paster (2009) also found that another sequela of hypophosphatemia is hemolytic
anemia. Individuals with this condition have been found to have hyperparathyroidism,
anorexia periods with “refeeding syndrome”, usage of phosphate-binding antacids,
hepatic lipidosis, and diabetic ketoacidosis. The most common treatment for cats with
hypophosphatemia is a diet change. This change moves these cats from a phosphorus
restricted diet to a maintenance diet. They were also given sodium phosphate orally.
Intravenous (IV) treatment is only used in severe cases, because it is linked with kidney
failure, hypocalcemia, and tissue dystrophic mineralization (Paster, 2009).
Other Complications
Bleedorn (2008) lists other immediate complications that occur postoperatively
are hypertension and neurological signs. The occurrence of neurologic complications has
decreased with the better management of hypertension. In feline transplant recipients,
21% of them have central nervous system disorders after surgery. Eighty-eight percent of
these cats have had seizures (Bleedorn, 2008).
Toxoplasmosis has been found to be an uncommon sequela that may occur if the
transplanted kidney was from a healthy donor that was latently infected. Toxoplasmosis
was reactivated in the recipient due to immunosuppression (Bleedorn, 2008). Transplant
recipients are also more at risk for diabetes mellitus which increases the risk of infection
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even more. The recipients are also more likely to develop neoplasia. The most common is
lymphoproliferative neoplasms (Bleedorn, 2008).
Kidney Biopsies
After transplantation, one of the feline recipient’s dead kidneys is biopsied. This
is done for prognostic and diagnostic reasons (Bleedorn, 2008). De Cock (2004) argues
that a standard way to interpret kidney allographs is needed. This is particularly important
for clinical trials of anti-rejection treatments. In 1991, the first meeting to discuss the
need for human kidney rejection classification was held in Banff, Canada. At this
meeting they created the first classification guideline called the Banff ’91. Since this
meeting there have been many updates to the classification guidelines. The Banff ’97
separates all kidney allograft biopsies in to five different categories: normal, anti-body
mediated rejection, borderline changes, acute or active rejection, and sclerosing or
chronic allograft nephropathy (De Cock, 2004).
De Cock (2004) argues that these human rejection classifications can also be used
in felines. The kidney samples are taken from one of the removed kidneys from the feline
transplant recipient. This sample had to contain at least one artery and 20 glomeruli. The
sample was given a score depending on the state of the glomeruli, tubules, vessels,
interstitium, and the parenchymal components. These scores correlate with one of the five
categories of biopsies. The classification of the recipient feline’s original kidney
determined what treatments the feline should receive to prevent rejection of the donor
kidney (De Cock, 2004).
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Conclusion
Due to the high rate of complications, the potential benefits must outweigh the
potential cost for kidney transplants to be considered as a viable treatment option for
felines. The rejection and complication rates have decreased with the development and
improvement of outcome predictions, pre-transplantation screening, surgical methods,
immunosuppression, and post-transplant monitoring procedures. All of these
improvements have increased the average survival time after transplantation. To
determine if a feline is a good candidate for either donation or transplantation many
evaluations and prescreening must be done to predict the outcome. The surgical
procedures have changed drastically in the last twenty years to lower the rate of
complications and make the surgery more efficient. The development of
immunosuppression drugs was the biggest breakthrough in preventing kidney allograft
rejection episodes. The more extensive post-transplant monitoring protocols have helped
to find post-transplant complications in a timely manner to better prevent rejection and
improve the quality of life of the recipient. Overall, kidney transplants in felines is a
beneficial treatment to chronic kidney disease and late-stage kidney failure.
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